The mission of TissueX Technologies is to accelerate the discovery, development, and validation of therapies with its cell- and tissue-based technologies. TissueX’s platforms provide unique predictive data sets to indicate effectiveness in patients much earlier in the pipeline compared to other models which are not as predictive. In the long-term, the company plans to integrate machine learning algorithms and robotics to further improve the efficiency of drug development. The company aims to expand its predictive human tissue models to a wide range of human organs and transform into a drug and cell-based therapy company by leveraging the insights gathered during its first two major phases of company development.
Engineered tissues for drug development and biomedical research